Evaluation of symptomatic slow-acting drugs in osteoarthritis using the GRADE system
<p style="text-align:justify;"> <b>Background:</b> Symptomatic slow-acting drugs (SYSADOA) have been largely studied over the last decade. The objective of this study is to prepare a document providing recommendations for the use of SYSADOA in osteoarthritis (OA). <br...
Автори: | Bruyère, O, Burlet, N, Delmas, P, Rizzoli, R, Cooper, C, Reginster, J |
---|---|
Формат: | Journal article |
Мова: | English |
Опубліковано: |
BioMed Central
2008
|
Схожі ресурси
Схожі ресурси
-
Evaluation of symptomatic slow-acting drugs in osteoarthritis using the GRADE system
за авторством: Rizzoli René, та інші
Опубліковано: (2008-12-01) -
SYMPTOMATIC SLOW ACTING DRUGS IN THE TREATMENT OF OSTEOARTHRITIS
за авторством: L. I. Alekseeva
Опубліковано: (2012-04-01) -
Advantages of osteoarthritis combined treatment with symptomatic slow-acting drugs
за авторством: E. V. Zonova
Опубліковано: (2021-04-01) -
The use of symptomatic slow-acting drugs for osteoarthritis of the joints of the hands: Accent on microcirculation parameters
за авторством: A. S. Trofimova, та інші
Опубліковано: (2024-03-01) -
Multimorbidity in osteoarthritis and pleiotropic effects of slow-acting symptomatic drugs. Resolution of the multidisciplinary International Expert Council
за авторством: V. I. Mazurov, та інші
Опубліковано: (2023-10-01)